Revalor® G

A slow release anabolic agent containing trenbolone acetate and oestradiol which increases rate of mass gain in feedlot cattle (bulls, feeder steers and heifers)

FOR ANIMAL USE ONLY

Reg. No. G2714 (Act 36/1947)

INDICATIONS

For cattle

Revalor®-G is a slow release anabolic agent containing trenbolone acetate and oestradiol which increases the rate of mass gain in cattle (bulls, feeder steers and heifers).

COMPOSITION

Each dose is equivalent to 40 mg trenbolone acetate and 8 mg oestradiol.

(2 small yellow pellets, each containing 20 mg of trenbolone acetate and 4 mg oestradiol).

STORAGE

  • Store unopened product at or below 25 °C.
  • Avoid excessive heat and humidity.
  • Use product before the expiry date.

WARNINGS

  • NOT TO BE USED IN ANIMALS INTENDED FOR SUBSEQUENT BREEDING, OR IN DAIRY ANIMALS.
  • Implant pellets in the back of the ear only.
  • Do not salvage the implanted site for human or animal consumption.
  • Store away from food and feed.
  • Dispose of any containers, disposable equipment and any other waste after use, in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008) and do not reuse for any other purpose.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

One implant containing 40 mg trenbolone acetate and 8 mg oestradiol is administered to each animal. The 2 pellets which make up the dosage of Revalor®-G are contained in 1 division of the multiple dose cartridges. There are 10 doses in each cartridge.

Site of implantation

After appropriately restraining the animal to allow access to the ear, clean the skin at the implant needle puncture site.

The site of implantation is the soft skin on the posterior aspect of the ear.

The implant should be placed as far from the head as possible without inserting the implanter needle into the area where the skin is firmly attached to the cartilage.

THE IMPLANT MUST NOT BE PLACED CLOSER TO THE HEAD THAN THE EDGE OF THE CARTILAGE RING FARTHEST FROM THE HEAD.

The location of insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site.

Care should be taken to avoid injuring the major blood vessels or cartilage of the ear.

Fig. 1 – Ear of bovine ready for implantation

Fig. 2 – Rear view of the bovine ear showing the site for insertion of the implanter needle

PRESENTATION

Contains 100 doses in 10 cartridges with 10 implants per cartridge.

REGISTRATION HOLDER

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan

1619, RSA

Tel: +27 (0) 11 923 9300

E-mail: msdahaz@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF PACKAGE INSERT

2 March 2007